Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Dysplasia 1Squamous Intraepithelial Lesions 1Pancreatic Neoplasms 1NSCLC 1Carcinoma, Hepatocellular 1

Interventions

VGX-3100 4Light Coagulation 3Biopsy 3Watchful Waiting 2Observation 2Laser Therapy 2Imiquimod 2Fluorouracil 2Electroporation 2Colposcopy 2Cidofovir 2Aminolevulinic Acid 24,4'-dihydroxybenzophenone-2,4-dinitrophenylhydrazone 2epigallocatechin gallate 1calcipotriene 1Solutions 1Restraint, Physical 1Red Light 1Radiofrequency Ablation 1Probiotics 1Polymerase Chain Reaction 1Mindfulness-Based Stress Reduction 1Megestrol Acetate 1Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 1Human Papillomavirus DNA Tests 1Gene Expression Profiling 1Gels 1GPI0100 1Folic Acid 1Electroporation Therapies 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Squamous Intraepithelial Lesions × Antigens × Clear all
NCT02576561 2017-10-25

Safety and Efficacy Study of TVGV-1 Vaccine to Treat HPV Induced Cervical HSIL

THEVAX Genetics Vaccine

Phase 2 Unknown
10 enrolled
Gynecologic

Squamous Intraepithelial Lesions, Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡